Last reviewed · How we verify

NCT05576753: PUMA

Preperitoneal Umbilical Mesh Area

Status unknown NA Last updated 22 March 2023
What this trial tests

NA trial testing Hernia repair in Ventral Hernia in 20 participants. Status unknown.

Timeline
1 February 2023
Primary endpoint
31 December 2023
1 April 2025

Quick facts

Lead sponsorAlgemeen Ziekenhuis Maria Middelares
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment20
Start date1 February 2023
Primary completion31 December 2023
Estimated completion1 April 2025
Sites1 location across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

Algemeen Ziekenhuis Maria Middelares — full company profile →

Who can join

18 and older, any sex, with Ventral Hernia or Umbilical Hernia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to measure the mesh shrinkage and the visualization of the mesh with MRI scan at 1 month and 13 months after robot assisted preperitoneal hernia repair using the visible CICAT mesh (Dynamesh®).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Hernia repair

Trials testing the same drug.

Other recruiting trials for Ventral Hernia

Currently open trials in the same condition.

Other Algemeen Ziekenhuis Maria Middelares trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05576753.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing